This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Wyeth Holdings Corporation, De Staat Der Nederlanden, De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur. Active years: 1991-2007.
Company Filing History:
2 out of 113 
1 out of 2 
1 out of 3 Years Active: 1991-2007
Title: Jan T Poolman: Innovator in Meningococcal Vaccine Development
Introduction
Jan T Poolman is a notable inventor based in Broek in Waterland, Netherlands. He has made significant contributions to the field of immunology, particularly in the development of vaccines against meningococcal disease. With a total of 4 patents to his name, Poolman's work has had a lasting impact on public health.
Latest Patents
Among his latest patents are the "Recombinant microorganism expressing meningococcal class 1 outer membrane protein" and the "Meningococcal class 1 outer-membrane protein vaccine." These innovations focus on utilizing outer-membrane vesicles and class 1 outer membrane proteins to create effective immunization strategies against meningococcal disease. His research emphasizes the importance of fragments or oligopeptides containing epitopes of the Class I OMP in vaccine development.
Career Highlights
Throughout his career, Jan T Poolman has worked with prominent organizations such as Wyeth Holdings Corporation and the Dutch Ministry of Health, Welfare and Sport. His expertise in vaccine development has positioned him as a key figure in the fight against infectious diseases.
Collaborations
Poolman has collaborated with esteemed colleagues, including Peter Hoogerhout and Peter Andre Van Der Ley. These partnerships have furthered his research and contributed to advancements in vaccine technology.
Conclusion
Jan T Poolman's innovative work in the field of meningococcal vaccines showcases his dedication to improving public health through scientific research. His contributions continue to influence the development of effective immunization strategies.